DJIA 16,880.05 -162.85 -0.96%
NASDAQ 4,441.78 -51.61 -1.15%
S&P 500 1,958.97 -13.32 -0.68%
market minute promo

Exelixis (NASDAQ: EXEL)

1.53 0.00 (0.00%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

EXEL $1.53 0.00%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $1.58
Previous Close $1.53
Daily Range $1.48 - $1.63
52-Week Range $1.48 - $8.41
Market Cap $298.5M
P/E Ratio -1.01
Dividend (Yield) $0.00 (0.0%)
Volume 1,302,098
Average Daily Volume 5,832,968
Current FY EPS -$1.43





Exelixis (EXEL) Description

A development-stage biotechnology company dedicated to the discovery and development of novel small molecule therapeutics for the treatment of cancer and other serious diseases. Website:

News & Commentary Rss Feed

Big News for These 5 Stocks From ESMO

But smaller biotechs Clovis Oncology and Exelixis also benefit from the big boys' data.

Why Exelixis, Inc. Stock Is Soaring Today

Shares of small-cap biopharma Exelixis Inc. are up big today. Here's why.

Update: Exelixis Announces Very Positive Results From The CoBRIM Trial - Impacts To My Bull Thesis

Morning Market Movers

5-year lows: National Presto Industries, Ennis Inc, Landauer Inc, and Exelixis Inc.

Why Exelixis (EXEL) Stock Might be a Great Pick - Tale of the Tape

Anika Therapeutics: A Recent Greenblatt Small Cap Biotech Pick

Stocks Hitting 52-Week Lows

Tokai Pharmaceuticals IPO: Lack Of Product Diversity Should Leave Investors Cautious

Why Exelixis Inc. Stock Crashed By 70% in 2014

Exelixis stock got mauled after its lead drug failed to impress in a key late-stage study. Find out whether there's any hope left for this biotech stock or if it's time for investors to kiss it goodbye.

See More EXEL News...

EXEL's Top Competitors

EXEL $1.53 (0.00%)
Current stock: EXEL
TMO $120.85 (-0.70%)
Current stock: TMO
ILMN $159.86 (-2.48%)
Current stock: ILMN
WAT $98.79 (-0.33%)
Current stock: WAT